Ipsen has expanded its R&D pipeline once again, agreeing a $1.8 billion alliance with Skyhawk Therapeutics focused on the development of RNA-targeting therapies for rare neurological diseases. The ...
Do you ever feel disconnected from politics and politicians? Many of us want to improve our communities but it's not always easy to find the right ways of helping. Perhaps the answer is to reconnect ...
The new platform wants to professionalize a $30 billion secondary market long defined by handshakes and hope.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback